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Abstract
Introduction: Transanal microscopic surgery is an important application of minimally invasive surgery of rectum,
allowing realization of complex transanal intervention.
Patients and Methods: During the period between January 2002 and December 2010, seven patients, five men
and two women, average age 75 years, with early rectal cancer recurrence were selected for this type of surgical
palliative procedure. The selection of the patients is made by: transrectal ultrasonografy, colonoscopy and
abdominal ultrasonografy, to rule out liver metastases, CT with and without enema, PET CT. Follow-up is
approximately 12-30 months.
Results: The pathologic staging confirms the complete excision of recurrences. Then patients are referred for more
complementary therapies.
Discussion: The significance of conservative treatment for local recurrence of rectum adenocarcinoma is still
controversial because the recurrence is an expression of tumor spread not controlled by oncological surgical and
radio/chemo therapy.
Conclusion: In selected subjects such as the elderly, based on equal oncological treatment, the reduction of
surgical trauma, preservation of anatomical integrity and resolution of symptoms are important results.
Introduction
The microscopic trans-anal surgery, born from an idea
by g. Buess, has over 25 years.
Thanks to a continuous improvement of surgical
instruments, it’s possible realization of complex transa-
nal surgical procedure, like excisions of full thickness
resection with anastomotic reconstructions.
Due to the effectiveness achieved, it possible to treat
complex cancer cases, in accordance with the improve-
ment of adjuvant and neoadjuvant chemo/radiotherapy.
For patients with stage I T1/T2 rectal cancer, local man-
agement of rectal cancer has been increasingly considered
as an alternative to traditional transabdominal resection.
Given the increasing interest in organ and sphincter
preservation, LE has rapidly gained appeal. However, its
oncologic adequacy remains controversial [1-5].
In our experience, we have extended the use of TEM
in palliative treatment of adenocarcinoma recurrence
after surgery in the elderly, where the resolution of the
symptoms, like bleeding and/or sub-occlusion, the maxi-
mization of survival benefit, minimization of disease
recurrence, and preservation of preoperative bowel func-
tion are acceptable results in select cases, allowing you
to avoid overly demolition surgery, especially in relation
to age-related comorbidities.
Patients and Methods
The instruments used is composed of a operator recto-
scope of 4 cm diameter with variable length from 12 to 20
cm, and operating 4 channels.
The sigmoidoscope is fixed to operating table with
mechanical arm while a combined endosurgery unit deli-
vers CO2 in rectum to obtain a dilation at a constant
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pressure of 12-14 mmHg. The HD optic provides a three-
dimensional view and play back images on the monitor.
In the period between January 2010 and December
2012, 7 patients, 5 males and 2 females, average age 75
years, have undergone minimally invasive surgical treat-
ment for recurrent adenocarcinoma of rectum.
4 males and 1 female were subjected to ultra-low
anterior resection of rectum adenocarcinoma followed
by cycles of adjuvant chemo/radio therapy.
The lesions were assessed as T3N1M0 at histological
examination.
1 woman had been subjected to TEM as first procedure
for a lesion evaluated as T1NxM0 and in 1 male patient,
78 years old, local excision was performed after cycles of
neoadjuvant chemo/radio terapy for a T2NxM0 lesion.
During the follow-up, approximately 22-28 months after
first surgery, cancer recurrence is presented.
In this period patients underwent blood tests to check
in particular cancer markers, half-yearly CT Total Body
to assess lymph node and metastases and annual colo-
noscopy to evaluate possible recurrence and/or new
colonic lesions. In all patients recurrence is contained in
rectum at level of the rear wall and less than 2 cm in
diameter (evaluation obtained by execution of trans rec-
tal ultrasonografy at identification of new lesions).
In all cases the subjects have refused major surgery in
relation to ‘high risk intra-, peri-and postoperative mor-
tality related to age-related comorbilities present.
Results
The mean operating time is 50 min (range 10-110) and
blood loss is < 50 ml in all patients. Histological results
confirms the complete excision of recurrence. Two
patients experience postoperative complications. One
develops acute urinary retention. One patients develops
pelvic sepsis, for which a defunctioning ileostomy is
formed and subsequently reversed. There are no proce-
dure-related deaths. The median hospital stay is 4 days
(range 2-14). Follow up is approximately 12-30 months.
Patients are referred then for more complementary thera-
pies. Two patients have developed distant metastases. One
patients with T3 carcinoma develops brain metastases at
30 months post TEM and died. The other patient develops
liver metastases 25 months after TEM for a T2 carcinoma.
Discussion
Radical surgery with mesorectal excision is considered
the oncological standard in the curative treatment of
rectal cancer. Independent of the cancer stage, the com-
plication rates of elective RS are reported to be as high
as 30-40% (including impotence and urological dysfunc-
tion) with a mortality rate of 2-5% and a definitive
colostomy is required in approximately 30% of these
patients [6-9]. Compared with RS, the main advantage
of limited surgical intervention is the appreciably lower
morbidity and mortality rates and the better functional
results. As previously pointed out, preoperative staging is
a challenge, even using the best available techniques, but
due to the risk of lymph node metastases, preoperative
correct definition of the lesion’s extension is mandatory
to avoid unnecessary major surgery and complications.
Although some authors included tumor size in the
preoperative selection criteria, we understood there were
no conclusive data to support this point and, instead of
the size by itself, the inclusion criteria was the tumor
suitability for getting adequate free margins. More
recently neoadjuvant or adjuvant radiotherapy with or
without chemotherapy has been used to improve local
recurrence rates following local excision of rectal can-
cers. Local recurrence for T2-3, N0 rectal tumours after
TEM with neoadjuvant chemoradiotherapy is reported
to be comparable to that following laparoscopic resec-
tion. Reduction in tumour size after neoadjuvant che-
moradiotherapy was found to be the most reliable
prognostic factor of success of local excision [10,11].
The significant differences between LE and SR as
described earlier constitute the fundamental considera-
tion when assessing the oncologic adequacy of LE versus
SR in T1/T2 tumors.
First there is evidence that tumor extension in the
bowel wall distal to the palpable tumor edge is relatively
uncommon. Second LE does not aim to remove the
mesorectum, whereas SR aims to remove the entire
mesorectal package. The general incidence of occult
nodal involvement in T1 tumors ranges from 10% to
13%. The rate increases to at least17%to22%for T2
tumors. Same predictive models were developed to pre-
dict nodal involvement based on T stage and other fac-
tors including patient age, tumor histology, degree of
differentiation, lymphocytic infiltration, and evidence of
vascular or perineural invasion. Third, preoperative
selection of patients for TEM or SR depends on the
accuracy of clinical staging by preoperative imaging
[12-16]. Reviewed in detail elsewhere, the preoperative
staging of rectal adenocarcinoma has significantly
improved but remains imperfect. The most commonly
used imaging modalities include endoscopic ultrasound
(EUS) and magnetic resonance imaging (MRI). The
reported stage-specific sensitivities and specificities of
EUS are T1 (88% and 98%), T2 (81% and 96%), T3 (96%
and 91%), and T4 (95% and 98%); corresponding sensi-
tivity and specificity for nodal staging are 73% (95% con-
fidence interval, 71%-76%) and 76% (95% confidence
interval, 74%-78%), respectively. Finally, for patients who
undergo LE but later develop a recurrence in the pelvis,
salvage operations typically involve multivisceral pelvic
resections, with morbidity rates of 34% and R0 resection
rates between 79% and 94%. The 5-year disease-free
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survival after salvage surgery ranges between 53% and
59% at best. By contrast, for patients who undergo LE
but were found to have either a T3 lesion, evidence of
lymphovascular invasion, or gross residual disease on
pathology, proceeding to immediate salvage resection
does not appear to compromise long-term outcomes,
with reported 5-year overall survival rates of 79% [17-21].
Thus, the risk of delayed failure after LE may be costly
and the importance of vigilant tumor surveillance after
resection underscored. Current evidence suggest that
local surgical excision may be considered as an alterna-
tive to SR only in very select few patients whose disease
is confined and tumor biology is highly favourable
[22-25]. In the current era of personalized medicine, the
optimal treatment plan for an individual patient requires
a well-informed discussion. A careful consideration of
multiple key factors would inform an individualized ana-
lysis of benefits and risks of LE versus SR [17-20]. New
approaches in multimodality therapy aimed at improving
oncologic outcome after LE alone have emerged but
remain in the setting of clinical trials [26-28].
Conclusions
Recurrence of rectal cancer constitute a failure to control
by the previous surgical procedure. The subsequent sur-
gical approach after ultra low resection is abdominal
perineal resection sec Milles. This complex procedure is
to be burdened not only by complicaze like bleeding,
urinary disorders, abscesses, etc., but it is also a proce-
dure extremely disability due to permanent loss of
sphincter function. In addition, this procedure may not
be oncologically safe for possibility of lymph node micro-
metastases not properly evaluated and controlled. For
this reason, in selected subjects such as the elderly, TEM
may be a possible alternative to radical surgery where the
resolution of symptoms such as bleeding, sub-occlusion
can be a successful in relation to high-risk surgical and
anesthetic related to co-morbidity age related.
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